Diagnosing and treating hypersomnolence in depression

Area of Science:

• Psychiatry and Sleep Medicine
• Neuroscience

Background:

• Hypersomnolence, including excessive daytime sleepiness, affects approximately 25% of individuals with major depressive disorder.
• This condition is frequently overlooked in clinical practice, hindering mood disorder remission and reducing quality of life.

Purpose of the Study:

• To propose a diagnostic approach integrating psychiatric and sleep medicine classifications for hypersomnolence in depression.
• To offer a multimodal treatment algorithm for managing hypersomnolence in patients with comorbid depression.

Main Methods:

• This narrative review synthesizes current knowledge on hypersomnolence in depression.
• It examines existing pharmacological and non-pharmacological treatment options.
• It proposes an integrated diagnostic and therapeutic framework.

Main Results:

• Current pharmacological treatments like SSRIs are often insufficient.
• Noradrenaline and dopamine reuptake inhibitors may be indicated.
• Emerging treatments include low-sodium oxybate (for Idiopathic Hypersomnia), cognitive behavioral therapy for hypersomnia, and light therapy.

Conclusions:

• A structured approach is needed to diagnose and treat hypersomnolence in depression.
• Multimodal treatment strategies combining pharmacological and non-pharmacological interventions are likely most effective.
• Further research is required to establish the efficacy of specific treatments, such as low-sodium oxybate, in this population.